// App-Quantinova.ai

1362 : Low Expression Of BCL11B Predicts Poor Overall Survival In Adult Standard Risk T-ALL

Researchers

Presenter

  • Isabelle Bartram

Principal Investigators

  • Nicola Gokbuget

  • Cornelia Schlee

  • Sandra Heesch

  • Lars Fransecky

  • Stefan Schwartz

  • Dieter Hoelzer

  • Martin Neumann

  • Claudia D. Baldus

Medical Centers

  • Medical Department II, Hematology and Oncology, Goethe University Hospital, Frankfurt, Germany

  • Dept of Pediatrics, University Hospital Frankfurt, Frankfurt, Germany

  • Hematology and Oncology, Charite Campus Benjamin Franklin, Berlin, Germany

  • Department of Hematology and Oncology, Charite Campus Benjamin Franklin and Mitte, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Angiomodulin

  • Neurogenic locus notch homolog protein 1

  • B-cell lymphoma/leukemia 11B

  • Cluster of Differentiation 34

  • ETS transcription factor ERG

  • Fms related tyrosine kinase 3

  • GATA Binding Protein 3

  • Granulin precursor

  • WT1 Transcription Factor

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved